Chapter 89

## Abstract

Abstract

1. Sarcosinemia is a phenotype characterized by increased concentration of sarcosine (N-methylglycine) in plasma and increased excretion of sarcosine in urine. Sarcosinemia occurs because of a defect in the conversion of sarcosine to glycine that is catalyzed by sarcosine dehydrogenase. A deficiency of sarcosine dehydrogenase can occur because of a genetic alteration in the apoenzyme, a dysfunction of a necessary electron transfer flavoprotein, or a severe deficiency of folic acid.

2. The formation and degradation of sarcosine occur in liver and kidney tissue. Sarcosine is formed enzymatically from dimethylglycine by dimethylglycine dehydrogenase (EC 1.5.99.2) and converted to glycine by sarcosine dehydrogenase (EC 1.5.99.1). A small fraction of sarcosine may be generated from glycine by the enzyme glycine methyltransferase (EC 2.1.1.20)

3. It was originally reported that sarcosinemia was causally related to mental retardation or neurologic problems. It is most probable that sarcosinemia is a “benign” condition that is unrelated to neurologic symptoms or significant clinical problems.

4. Sarcosinemia that occurs from a genetic deficiency of sarcosine dehydrogenase activity is inherited as an autosomal recessive condition. The incidence of sarcosinemia found in newborn screening programs that evaluate urine specimens has varied from 1/350,000 (New England) to 1/28,000 (Quebec). Detection of heterozygotes by sarcosine loading studies is unreliable. The gene for human sarcosine dehydrogenase has been cloned and is located on chromosome 9q34.

5. A mouse with the phenotype of sarcosinemia and sarcosinuria has been identified. In the mouse, sarcosinemia has occurred from a deficiency of sarcosine dehydrogenase activity in liver mitochondria. The phenotype is genetically transmitted as an autosomal recessive trait, and the gene has been mapped to chromosome 2 within 15 to 18 cM of the centromere.

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### OMMBID Full Site: One-Year Subscription

Connect to the full suite of OMMBID content including new and revised chapters that reflect the latest research, image galleries, clinical phenotypes, and more.